SpectraCure at Stora Aktiedagen in Gothenburg

Masoud Khayyami VD SpectraCure

A new opportunity to listen to Masoud Khayyami, CEO of SpectraCure, will be at Stora Aktiedagen in  Gothenburg November 4th. 

The SpectraCure Company presentation, including the status of current clinical study, will be held at 1.30 p m. The event will be streamed at  www.aktiespararna.se/tv/live.

Where:  Hall G3, Svenska Mässan, Mässans Gata 24, Gothenburg
   

For further information, contact:

SpectraCure AB publ, CEO, Masoud Khayyami, phone: +46(0) 70 815 21 90
Certified Adviser is G&W Fondkommission, e-mail: ca@gwkapital.se, phone: +46-(8)-503 000 50.

Release
IMG 0301

SpectraCure is developing the future systems for the treatment of internal solid cancer tumours. The goal of the proprietary and patented treatment system is to eliminate deep-seated cancer tumours and prolong the survival of cancer patients while maintaining their quality of life. When prostate cancer recurs, there are often no established treatment options other than lifelong hormone therapy, with its associated side effects. 

Facebook Linkedin Envelope